First Time Loading...

Chengdu Kanghua Biological Products Co Ltd
SZSE:300841

Watchlist Manager
Chengdu Kanghua Biological Products Co Ltd Logo
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Watchlist
Price: 62.4 CNY -2.53% Market Closed
Updated: May 13, 2024

Wall Street
Price Targets

Price Targets Summary
Chengdu Kanghua Biological Products Co Ltd

Wall Street analysts forecast Chengdu Kanghua Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chengdu Kanghua Biological Products Co Ltd is 83.61 CNY with a low forecast of 82.79 CNY and a high forecast of 86.07 CNY.

Lowest
Price Target
82.79 CNY
33% Upside
Average
Price Target
83.61 CNY
34% Upside
Highest
Price Target
86.07 CNY
38% Upside
Chengdu Kanghua Biological Products Co Ltd Competitors:
Price Targets
ALERS
Eurobio Scientific SA
111% Upside
IONS
Ionis Pharmaceuticals Inc
45% Upside
IPSC
Century Therapeutics Inc
383% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
61% Upside
4597
Solasia Pharma KK
221% Upside
NGNE
Neurogene Inc
52% Upside
IOVA
Iovance Biotherapeutics Inc
142% Upside
FYB
Formycon AG
131% Upside

Revenue
Forecast

Revenue Estimate
Chengdu Kanghua Biological Products Co Ltd

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's revenue is 23%. The projected CAGR for the next 2 years is 13%.

23%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Chengdu Kanghua Biological Products Co Ltd

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's operating income is 26%. The projected CAGR for the next 2 years is 28%.

26%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Chengdu Kanghua Biological Products Co Ltd

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's net income is 27%. The projected CAGR for the next 2 years is 25%.

27%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chengdu Kanghua Biological Products Co Ltd's stock price target?
Price Target
83.61 CNY

According to Wall Street analysts, the average 1-year price target for Chengdu Kanghua Biological Products Co Ltd is 83.61 CNY with a low forecast of 82.79 CNY and a high forecast of 86.07 CNY.

What is Chengdu Kanghua Biological Products Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's revenue is 23%. The projected CAGR for the next 2 years is 13%.

What is Chengdu Kanghua Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's operating income is 26%. The projected CAGR for the next 2 years is 28%.

What is Chengdu Kanghua Biological Products Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 5 years the compound annual growth rate for Chengdu Kanghua Biological Products Co Ltd's net income is 27%. The projected CAGR for the next 2 years is 25%.